107 related articles for article (PubMed ID: 12417087)
1. [The expressions of TGF-beta1 and Smad 2 mRNA on diseased glomeruli and their significance in the development of glomerulosclerosis].
Ruan Y; Zhang Z; Zhang X; Liu C; Guo M
Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):314-7. PubMed ID: 12417087
[TBL] [Abstract][Full Text] [Related]
2. Glomerular transforming growth factor-beta1 mRNA as a marker of glomerulosclerosis-application in renal biopsies.
Yang CW; Hsueh S; Wu MS; Lai PC; Huang JY; Wu CH; Hu SA; Chen JF; Huang CC
Nephron; 1997; 77(3):290-7. PubMed ID: 9375822
[TBL] [Abstract][Full Text] [Related]
3. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
4. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis.
Kim JH; Kim BK; Moon KC; Hong HK; Lee HS
Kidney Int; 2003 Nov; 64(5):1715-21. PubMed ID: 14531804
[TBL] [Abstract][Full Text] [Related]
5. mRNA expression of glomerular basement membrane proteins and TGF-beta1 in human membranous nephropathy.
Kim TS; Kim JY; Hong HK; Lee HS
J Pathol; 1999 Nov; 189(3):425-30. PubMed ID: 10547606
[TBL] [Abstract][Full Text] [Related]
6. In situ expression of connective tissue growth factor in human crescentic glomerulonephritis.
Kanemoto K; Usui J; Nitta K; Horita S; Harada A; Koyama A; Aten J; Nagata M
Virchows Arch; 2004 Mar; 444(3):257-63. PubMed ID: 14758550
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta(1) and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease.
Goumenos DS; Tsamandas AC; Oldroyd S; Sotsiou F; Tsakas S; Petropoulou C; Bonikos D; El Nahas AM; Vlachojannis JG
Nephron; 2001 Mar; 87(3):240-8. PubMed ID: 11287759
[TBL] [Abstract][Full Text] [Related]
8. [Change of gene expression of transforming growth factor-beta1, Smad 2 and Smad 3 in hypertrophic scars skins].
Chen W; Fu X; Sun T; Sun X; Zhao Z; Sheng Z
Zhonghua Wai Ke Za Zhi; 2002 Jan; 40(1):17-9. PubMed ID: 11955370
[TBL] [Abstract][Full Text] [Related]
9. Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling.
Fukasawa H; Yamamoto T; Suzuki H; Togawa A; Ohashi N; Fujigaki Y; Uchida C; Aoki M; Hosono M; Kitagawa M; Hishida A
Kidney Int; 2004 Jan; 65(1):63-74. PubMed ID: 14675037
[TBL] [Abstract][Full Text] [Related]
10. Role of transforming growth factor-beta 1 in glomerulonephritis.
Taniguchi Y; Yorioka N; Masaki T; Yamashita K; Ito T; Ueda H; Yamakido M
J Int Med Res; 1997; 25(2):71-80. PubMed ID: 9100161
[TBL] [Abstract][Full Text] [Related]
11. Kidney expression of RhoA, TGF-beta1, and fibronectin in human IgA nephropathy.
Mattii L; Segnani C; Cupisti A; D'Alessandro D; Moscato S; Meola M; Barsotti G; Marinò M; Bianchi F; Dolfi A; Bernardini N
Nephron Exp Nephrol; 2005; 101(1):e16-23. PubMed ID: 15925904
[TBL] [Abstract][Full Text] [Related]
12. Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo.
Quan T; He T; Kang S; Voorhees JJ; Fisher GJ
J Invest Dermatol; 2002 Aug; 119(2):499-506. PubMed ID: 12190876
[TBL] [Abstract][Full Text] [Related]
13. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
[TBL] [Abstract][Full Text] [Related]
14. Activation of the Smad pathway in glomeruli from a spontaneously diabetic rat model, OLETF rats.
Furuse Y; Hashimoto N; Maekawa M; Toyama Y; Nakao A; Iwamoto I; Sakurai K; Suzuki Y; Yagui K; Yuasa S; Toshimori K; Saito Y
Nephron Exp Nephrol; 2004; 98(3):e100-8. PubMed ID: 15528945
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.
Yoshioka K; Takemura T; Murakami K; Okada M; Hino S; Miyamoto H; Maki S
Lab Invest; 1993 Feb; 68(2):154-63. PubMed ID: 8441250
[TBL] [Abstract][Full Text] [Related]
16. The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system.
Ostendorf T; Kunter U; van Roeyen C; Dooley S; Janjic N; Ruckman J; Eitner F; Floege J
J Am Soc Nephrol; 2002 Mar; 13(3):658-667. PubMed ID: 11856769
[TBL] [Abstract][Full Text] [Related]
17. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
Del Prete D; Gambaro G; Lupo A; Anglani F; Brezzi B; Magistroni R; Graziotto R; Furci L; Modena F; Bernich P; Albertazzi A; D'Angelo A; Maschio G
Kidney Int; 2003 Jul; 64(1):149-59. PubMed ID: 12787405
[TBL] [Abstract][Full Text] [Related]
18. Expression of transforming growth factor-beta isoforms in human glomerular diseases.
Yamamoto T; Noble NA; Cohen AH; Nast CC; Hishida A; Gold LI; Border WA
Kidney Int; 1996 Feb; 49(2):461-9. PubMed ID: 8821830
[TBL] [Abstract][Full Text] [Related]
19. Burn-induced thymic apoptosis corresponds with altered TGF-beta(1) and Smad 2/3.
Hobson KG; Cho K; Adamson LK; Greenhalgh DG
J Surg Res; 2002 Jun; 105(1):4-9. PubMed ID: 12069494
[TBL] [Abstract][Full Text] [Related]
20. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
